BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Med BioGene Welcomes Renowned Expert to Lymphoma Collaboration

  September 12, 2007

   · 

  1 min read
• Drug Development

  Pharmacopeia, Inc. Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)

  September 12, 2007

   · 

  5 min read
• Drug Development

  Allon Therapeutics, Inc. Commences Phase II Schizophrenia Trial and Updates Clinical Progress

  September 12, 2007

   · 

  1 min read
• Drug Development

  Phosphagenics Limited to Commence Phase 2 TPM/Insulin Clinical Trial

  September 12, 2007

   · 

  3 min read
• Genetown

  Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting

  September 12, 2007

   · 

  5 min read
• Lone Star Bio

  Access Pharmaceuticals Highlighted in Recent BusinessWeek Article

  September 12, 2007

   · 

  3 min read
• BioMidwest

  Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial

  September 12, 2007

   · 

  3 min read
• Drug Development

  Anadys Pharmaceuticals, Inc. Presents Preclinical Results on ANA598

  September 12, 2007

   · 

  4 min read
• BioForest

  Oncolytics Biotech Inc. Release: Reovirus Infection of Melanoma Cells Generates Anti-Tumour Immunity

  September 12, 2007

   · 

  3 min read
• Genetown

  Genstruct, Inc. CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit

  September 12, 2007

   · 

  3 min read